Treatment Of Rheumatoid Arthritis
The fact that there are many anti-inflammatory drugs for RA should not blind patients into the belief that RA could be cured. The very opposite is true! Evidence shows that none of the treatment modalities is curative, but the best the patient can hope for is that the disease process gets more controlled and that the affected joints remain functional. In the following I will briefly summarize the available treatments in a table (gleaned from Ref. 1 and 2) and then comment on each item mentioned in more detail.
| Various treatment modalities for rheumatoid arthritis |
| Treatment type: |
Comments: |
| Initial treatment: |
side effects of initial treatment: |
| Nonsteroidal
antiinflammatories (NSAIDs) |
stomach irritation, kidney damage |
| COX-2 inhibitors |
more specific than NSAIDs |
| corticosteroids |
dramatic response, but only safe to use short-term |
| Slow acting drugs for second stage: |
added after 2-4 months if NSAIDs or COX-2 inhibitors are ineffective |
| gold |
injectable gold may cause remission |
| sulfasalazine |
benefits may take 6 weeks to show |
| hydroxychloroquine |
retinal degeneration limits its use |
| penicillamine |
affects bone marrow, kidneys, can produce a lupus like syndrome etc. |
| Immunosuppressive drugs for resistant cases of RA: |
used for severe, active RA; they have significant toxic side-effects on liver, bone marrow and immune cells |
| methotrexate |
affects bone marrow, lungs, liver |
| cyclosporine |
causes hypertension and kidney damage, hair growth, gingival hypertrophy |
| azathioprine |
used for synovitis, can cause lymphoma |
| cyclophosphamide |
has same side effects as all other immunosuppressive drugs, used for vasculitis by rheumatologist |
| Newer
approaches to treatment of rheumatoid arthritis |
Treatment of the initial
phase of RA:
COX-2
inhibitors, if the patient can afford it, are likely
the drugs of choice as they are not as toxic for the stomach lining
or the kidney blood vessels than the regular NSAIDs.
With the VIOXX withdrawal from the market there is now a shift
in treatment back to the regular anti-inflammatories (NSAIDS).
However, because RA is an autoimmune disease, this type of treatment only suppresses an acute flare-up. We know that untreated RA by itself will settle down in the first year in about 75% of the cases (Ref. 2). General supportive measures such as seeking the advice of a physiotherapist and occupational therapist to get splints made and to preserve as much range of motion as possible through passive exercises followed by active exercises, may be the most important thing to do for the patient. The patient should also use aids and appliances to make the surroundings as comfortable and safe as possible.
Corticosteroids orally or by joint injection,
if COX-2 inhibitors alone are not helping, might very quickly
settle the arthritis down with a short course of therapy not eceeding
2 weeks. However, if corticosteroids are used for more than 2
weeks, there is an increased risk for osteonecrosis of the hip
bone, which would lead to fractures and the need for emergency
hip replacements. Other problems of longterm corticosteroid therapy
are that the immune system gets paralyzed and serious infections
including systemic fungal infections can threaten the life of
patients.
Slow acting drugs for second stage:
If after 2 to 4 months there is still no relief from the joint pains and swelling, the patient should seek the advice of a rheumatologist or arthritis center. A decision needs to be made whether to add one of the slow acting drugs to control the inflammation of RA. Popular choices are either gold therapy or sulfosalazine. Each has its advantage and disadvantage.
Gold therapy, for instance, can sometimes show
impressive results with initial injections of gold (sodium aurothiomalate).
However, longterm treatment with gold is not tolerated as well
and toxic effects of gold therapy are becoming more evident as
time goes on and gold accumulates in the system. Patients with
liver or kidney disease are not allowed to get gold therapy as
gold itself affects liver (hepatitis) and kidneys (nephrotic syndrome)
negatively. Bone marrow suppression is another danger.
Sulfasalazine, which has been used for a long time for ulcerative colitis is often used now for RA. It may take up to 3 months before the full effect of this agent is visible in terms of improvement of joint swelling and pain. Side effects are gastric irritation, bone marrow suppression, anemia due to hemolysis and a skin rash. The rheumatologist will want to monitor the blood values closely while on this therapy. About 60% of patients put on this medication can still tolerate it after 3 years, but about 15% will have to stop it because of toxic side effects (Ref.1).
Hydroxychloroquine is an old anti-malarial drug that has been found in the past to be beneficial for RA patients. It is perhaps better tolerated, but it has one serious side effect, which limits its use: retinal damage due to an irreparable retinal degeneration. The rheumatologist likely will want to have an ophthalmologist examine the patient every 6 months while this medication is used. When the RA has stabilized, the minimum possible maintenance dosage is used to minimize risk (Ref.2).
Penicillamine is sometimes used by the rheumatologist
when gold therapy fails. However, side effects are more common
than with gold therapy and include toxicity to the bone marrow,
kidneys (nephrosis), nervous system (myasthenia gravis), skin
(pemphigus), muscles (polymyositis) and a lupus like syndrome.
If this medication is used, then the specialist will have to carefully
monitor for these side effects with ongoing blood tests (Ref.
1 and 2). A metallic taste and nausea are common, but often disappear
with continued use.
Use of immunosuppressive drugs for resistant RA cases:
If the other measures were unable to provide relief to the RA sufferer, the we are dealing with a particularly severe case of RA. The RF titer likely is very high and the C-reative protein as well. This means that the autoimmune bodies and the resulting immune complexes that are formed throughout the body continue to irritate the synovial membranes leading to more and more synovitis as well as joint and ligament destruction. In these cases it would theoretically make sense to dampen the immune system to control the RA. However, we are only at the beginning to learn how to this therapy without harming the rest of the body.
Methotrexate is one of the more popular medications. It is an anti-cancer agent and like all these chemotherapeutic agents has a bone marrow suppressant side effect. It cannot be used in patients who have a history of heavy alcohol consumption or in diabetics. Liver function must be monitored. Immune supression leads to sometimes serious viral or bacterial infections that can be life threatening. However, with low dose intermittent methotrexate therapy some patients can be well controlled with their RA (Ref.2).
Cyclosporine is the medication that is used to suppress the rejection of a trasplanted organ. The reason it can be useful for RA patients is that the autoimmune antibody production that leads to RF can be supressed with this medication. However, it is costly, and it has a toxic kidney effect that leads to high blood pressure. On the other hand it does not have the bone marrow toxicity that other agents have (Ref. 1). Other side effects are a tremor, excessive gum growth (gingival hypertrophy), increased hair growth and interaction with a large number of drugs.
Azathioprine seems to be useful when synovitis (swelling of the joint lining) is a prominent feature in RA. However, bone marrow and liver toxicity limit its use as well as the danger of development of a lymphoma with prolonged use (Ref. 1).
Cyclophosphamide is another chemotherapeutic drug that is used in certain cancers. It is somteimes used for very resistant RA cases where severe synovitis or vasculitis is resistant to other treatment modalities. However, like with methotrexate the rheumatologist must be careful to monitor vital organ functions (Ref.1).
Newer approaches to treatment
There is an FDA approved non-drug method available, IceWave
patches from Lifewave, which will control pain. This is
mentioned in the book "Breakthrough" by Suzanne Somers
(Ref. 11) where newer insights of antiaging medicine are also
reviewed. Although the patches are placed over acupuncture points,
there are no needles involved. Nanotechnology, a newer technology,
was used in the manufacturing of these patches and infrared (heat)
waves from body heat are utilized to stimulate an acupuncture
point, which modifies pain perception and reduces pain to half
or less. Medically this would be considered an excellent pain
reliever. For more info on the patches see the IceWave patches
from Lifewave link above (click "products"). In the
US a 5 pack of the IceWave spray is available that can be directly
sprayed onto the skin in the area where the pain is located.
Many of the anti-aging physicians in Ref. 11 point out that rheumatoid
arthritis is not only an inflammation of the joints, but also
a problem where toxic substances such as heavy metals have accumulated
over a long period of time. Ref. 11 mentions that the body can
be detoxified from heavy metals like mercury, lead and cadmium
using a non-drug method stimulating the body's own glutathione
and carnosine detoxification system (Y-Age
patches from Lifewave). This link tells you more about
this FDA approved detoxification method (click "products").
These two patches are applied on alternating days (for more info
see the Y-Age patches from Lifewave link above). In addition Ref.
11 points out that hormone rebalancing may be required (special
blood tests are done by an anti-aging physician who is knowledgeable
in bioidentical hormone replacement).
There is a consensus recently that RA responds best, if it is treated
more aggressively right in the beginning before the abnormal autoimmune
reaction has progressed too much. O'Dell reports in Ref.3 that
RA , which does not respond to methotrexate alone, will often
respond well to a combination of methotrexate with cyclosporine
or combination of methotrexate with leflunomide.
| Advertisement |
 |
Leflunomide is one of the newer disease modifying agents described in Ref. 4. It prevents the proliferation of activated lymphocytes by inhibiting a specific enzyme. Leflunomide is as effective as sulfasalazine or methotrexate. It improves physical function, prevents erosions on x-rays and improves quality of life (Ref. 4).
Other promising studies have shown that inhibition of the cytokine,
tumor necrosis factor (TNF), through specific monoclonal
antibodies (infliximab, etanercept and others ), will improve
the clinical response. They are given by repeated infusions in
intervals for infliximab (brandname: Remicade)
or by subcutaneous injection twice per week with etanercept (brandname:
Enbrel). Occasionally the rheumatologist
may combine one of these agents with methotrexate and it can be
more effective this way (Ref. 4 and 5), but at the same time side
effects such as various types of infections also become more common.
According to the authors of Ref. 6 the immunomodifiers that inhibit
TNF are a turning point in the therapeutic management of RA.
Food supplements have been used for a long time for RA, although they are not too useful in active treatment, they might have an important place in terms of prevention. There is the theory that a lot of arthritis, if not all of it, has something to do with the syndrome of insulin resistance (now more aften referred to as "metabolic syndrome" and the lack of omega-3 fatty acids in our modern diets, which are rich in sugar and starch (see Ref. 7).
This theory is supported by the observation that high insulin levels dysbalance the ecosanoid metabolism, which results in more cytokines like TNF that can cause arthritis. By avoiding intake of refined sugar and too much starch the insulin level can return to normal levels and by adding omega-3 fatty acids (evening primrose oil, fish oil) and extracts from New Zealand green lipped mussels the natural anti inflammatory properties of these food supplements can be utilized to strengthen the immune system. Ref. 8 is useful guide in terms of starting a zone type diet, where these principles are utilized. However, I am suggesting that patients with RA see a rheumatologist as well so that these latest immune modifiers mentioned above can also be taken, if the specialist thinks that this is necessary. The key is to stop the inflammatory autoimmune process that eats away the cartilage and bone around the joints in the body (erosive lesions adjacent to the joint on X-rays and periarthritic osteoporosis).
One interesting observation is that calorie restriction can
improve RA on the short term (Ref. 1,p.47). It was speculated
that his may mean that certain foods are allergenic and if they
would be avoided, RA would get better. Others say that the extra
calories lead to hyperinsulinism
and the dysbalance of cytokines mentioned above. There may be
a combination of several factors.
|